Franklin Resources Inc Harrow Health, Inc. Transaction History

Franklin Resources Inc

$346 Billion
Q3 2024

A detailed history of Franklin Resources Inc transactions in Harrow Health, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 12,817 shares of HROW stock, worth $499,991. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,817

Previous 242,445 94.71%

Holding current value

$499,991

Previous $5.06 Million 88.63%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$20.85 - $46.47 $4.79 Million - $10.7 Million	-229,628 Reduced 94.71%	12,817 $576,000
Q2 2024 Aug 14, 2024	SELL	$10.0 - $21.64 $393,670 - $851,901	-39,367 Reduced 13.97%	242,445 $5.06 Million
Q1 2024 May 13, 2024	SELL	$9.3 - $13.23 $115,403 - $164,171	-12,409 Reduced 4.22%	281,812 $3.73 Million
Q4 2023 Feb 09, 2024	BUY	$8.1 - $16.36 $520,441 - $1.05 Million	64,252 Added 27.94%	294,221 $3.3 Million
Q3 2023 Nov 13, 2023	BUY	$14.03 - $22.08 $176,399 - $277,611	12,573 Added 5.78%	229,969 $3.3 Million
Q4 2022 Feb 10, 2023	BUY	$10.28 - $14.78 $510,309 - $733,693	49,641 Added 29.59%	217,396 $3.21 Million
Q3 2022 Nov 14, 2022	BUY	$6.57 - $24.88 $494,064 - $1.87 Million	75,200 Added 81.25%	167,755 $2.03 Million
Q2 2022 Aug 11, 2022	BUY	$5.75 - $7.74 $209,616 - $282,161	36,455 Added 64.98%	92,555 $674,000
Q1 2022 May 13, 2022	BUY	$6.77 - $8.66 $379,797 - $485,826	56,100 New	56,100 $383,000
Q4 2021 Feb 11, 2022	SELL	$8.5 - $12.0 $134,300 - $189,600	-15,800 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.99 - $10.6 $110,442 - $167,480	15,800 New	15,800 $144,000

Others Institutions Holding HROW

# of Institutions

176

Shares Held

21.4M

Call Options Held

845K

Put Options Held

717K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.06B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Harrow Health, Inc. Transaction History